A
Ahmedin Jemal
Researcher at American Cancer Society
Publications - 568
Citations - 492750
Ahmedin Jemal is an academic researcher from American Cancer Society. The author has contributed to research in topics: Cancer & Population. The author has an hindex of 132, co-authored 500 publications receiving 380474 citations. Previous affiliations of Ahmedin Jemal include Centers for Disease Control and Prevention & Emory University.
Papers
More filters
Journal ArticleDOI
Annual Report to the Nation on the Status of Cancer, Part 1: National Cancer Statistics.
Farhad Islami,Elizabeth Ward,Hyuna Sung,Kathleen A. Cronin,Florence K. L. Tangka,Recinda L. Sherman,Jingxuan Zhao,Robert N. Anderson,S. Jane Henley,K. Robin Yabroff,Ahmedin Jemal,Vicki B. Benard +11 more
TL;DR: In this paper, the authors examined trends in stage-specific survival for melanoma of the skin (melanoma) in the United States from 2001 through 2017 and melanoma cases diagnosed during 2001-2014 and followed up through 2016 were obtained from the Centers for Disease Control and Prevention and National Cancer Institute-funded population-based cancer registry programs compiled by the North American Association of Central Cancer Registries.
Journal ArticleDOI
Racial Disparities in Stage-Specific Colorectal Cancer Mortality Rates From 1985 to 2008
TL;DR: The black-white disparities in CRC mortality increased for each stage of the disease, but the overall disparity in overall mortality was largely driven by trends for late-stage disease.
Journal ArticleDOI
Cancer statistics: Breast cancer in situ
Elizabeth Ward,Carol DeSantis,Chun Chieh Lin,Joan L. Kramer,Ahmedin Jemal,Betsy A. Kohler,Otis W. Brawley,Ted Gansler +7 more
TL;DR: Information is provided about occurrence and treatment patterns for the 2 major subtypes of in situ breast cancer in the United States—ductal carcinoma in situ and lobular carcinomas in situ—using data from the North American Association of Central Cancer Registries and the 13 oldest Surveillance, Epidemiology, and End Results registries.
Journal ArticleDOI
Annual number of lung cancer deaths potentially avertable by screening in the United States
TL;DR: An estimate of the annual number of lung cancer deaths that can be averted by screening is provided, assuming the screening regimens adopted in the NLST are fully implemented in the United States.
Journal ArticleDOI
Public health impact of achieving 80% colorectal cancer screening rates in the United States by 2018
Reinier G.S. Meester,Chyke A. Doubeni,Ann G Zauber,S. Luuk Goede,Theodore R. Levin,Douglas A. Corley,Ahmedin Jemal,Iris Lansdorp-Vogelaar +7 more
TL;DR: The authors evaluated the potential public health benefits of achieving 80% colorectal cancer screening rates in the United States by 2018 and found that achieving this goal would improve public health and economic well-being.